speakerspeaker
REGISTER NOW ADD TO CALENDAR VIEW PROGRAM

New partnerships formed during the Covid-19 era

Global pandemic brings attention to the fast-growing, $125bn vaccine market by 2030

Read more here

Biotechnology platforms to enable fast, customisable vaccines

Customisable biotechnology platforms manufacture COVID-19 vaccines faster than traditional methods.

Secure your place

New vaccine delivery technologies for better immune response

Clinical trials show delivery of vaccines via new techniques induce greater immune responses.

View the latest program

Expert Speakers to Date

  • Jasmin Samaras
    University College London
  • Antonio Roldao
    iBET
  • Philip Probert
    Centre for Process Innovation
  • Gregory Tobin
    Biological Mimetics
  • Yongxiu Yao
    The Pirbright Institute
  • Tom Tillett
    MBF Therapeutics
  • Fredrik Sundberg
    Cytiva
  • Kevin Killeen
    Matrivax Corporation
  • Anh Wartel
    International Vaccine Institute
  • Anna Särnefält
    CEPI

Past Attendees

  • The Pirbright Institute
  • VBI Vaccines
  • CPI
  • iBET
  • University College London
  • Harvard University
  • Bill & Melinda Gates Foundation
  • Cytiva
  • Biological Mimetics
  • MBF Therapeutics
  • Matrivax Corporation
  • International Vaccine Institute
  • CEPI
  • Technical University of Denmark
  • Merck
  • CanSino Biologics

Who should attend

  • Vaccine Research
  • Vaccine Development
  • Vaccine Manufacturing
  • Vaccine Technologies
  • Genetic Engineering
  • DNA and mRNA Technologies
  • Viral Vector-Based Vaccines
  • Nucleic Acid-Based Vaccines
  • Vaccine Delivery Platforms
  • Biological Engineering of Vaccines
  • Structural Vaccinology Projects
  • Advanced Live-Attenuated Vaccines
  • Inactivated Vaccine Development
  • Cost Reduction Strategies
  • Sales and Marketing Initiatives
  • Business Development
  • Clinical Trials and Approvals
  • Immunisation Research & Development
  • Manufacturing Research & Innovation
  • Research and Development
  • Strategy, Projects, & Public Affairs
  • Legal and Compliance Work
  • Equipment Certification Services
  • News Reporting and Journalism

Why Attend

The Vaccine Manufacturing Summit 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest vaccine technologies and techniques for developing and manufacturing next-generation vaccines…

view more...

Subscribe for updates:

The Premier Forum for Vaccine Development and Manufacturing

Welcome to the Vaccine Manufacturing Summit 2023, where global biotech and pharmaceutical companies will meet with leading vaccine developers to explore new vaccine manufacturing technologies to discover, develop, and manufacture next-generation vaccines.

Global vaccine manufacturers face practical challenges in manufacturing the latest vaccines to combat COVID-19 and other diseases. Producing safe and cost-effective vaccines speedily and on a mass scale in response to an emerging global health crisis is a priority for the pharmaceutical industry.

Extraordinary progress has been made in the development and manufacturing of vaccines. Today's leading vaccine manufacturers and biotech companies are leveraging technology transfer to ensure product quality, formulations and delivery, and optimising processes to manage supply chains to address global healthcare challenges.

This year’s Vaccine Manufacturing Summit 2023 is set to become the world’s leading exhibition and conference exclusively for the vaccine industry to meet and collaborate with a large array of vaccine technology experts and institutions to examine new technologies, technical know-how, and discuss the challenges associated with the development of novel manufacturing processes for next-generation vaccines.

Key topics on this year’s agenda include:

  • The fundamentals of vaccine discovery and development to accelerate innovation
  • Exploring innovative and disruptive technologies for biologics and vaccine manufacturing
  • Latest research in Quality-by-Design (QbD) analytics for vaccine development
  • Leveraging blockchain technology for vaccine manufacturing and supply chain solutions
  • Advances in vaccine processing, vaccination strategies, and thermostability
  • Case studies, clinical trials, and working with global vaccine manufacturers

This year's event will provide a forum for all stakeholders across the biotech and pharmaceutical industry including leading vaccine manufacturers, to network and build cross-market relationships to explore new technologies and technical know-how to address the global challenges in vaccine development.

Call for Presentation

If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading “Call for Papers - Vaccine Manufacturing Summit 2023”

Book now
To secure your place at Vaccine Manufacturing Summit 2023 or if you require more information, please contact delegates@iQ-Hub.com.

Key topics for 2023:

  • The fundamentals of vaccine discovery and development to accelerate innovation
    Understand vaccine manufacturers' perspective on sustainable vaccine development through next-generation bioinformatics and deep learning techniques.
  • Exploring innovative and disruptive technologies for biologics and vaccine manufacturing
    Analyse emerging trends in potential disruptive technology in vaccine formulation, manufacturing, development, and health care delivery.
  • Latest research in Quality-by-Design (QbD) analytics for vaccine development
    Explore innovations in Quality-by-Design (QbD) approaches in vaccine development and their implementation for the rapid development and deployment of high-volume vaccines.
  • Leveraging blockchain technology for vaccine manufacturing and supply chain solutions
    Evaluate the blockchain-enabled pharmaceutical cold chain and supply chain transparency through blockchain-based traceability.
  • Advances in vaccine processing, vaccination strategies, and thermostability
    Hear from leading vaccine developers on vaccine efficiency, stability monitoring technology, and vaccination strategies.
  • Case studies, clinical trials, and working with global vaccine manufacturers
    Gain insights from leading manufacturers and implement strategies that others in the industry use to ensure successful vaccine delivery.

Testimonials

  • Provided a great learning opportunity and served as a very good networking event.
    Mike Zimmer (Novartis)
  • I loved the show! Very informative conference and a great group of people.
    Wensheng Du (GlaxoSmithKline)
  • Excellent conference. Very useful information. Well organized event and agenda was very appropriate.
    Barry Rosen (Sanofi)
  • Highly informational event with lots of opportunities to engage with other people from the field.
    Ying Wang (Johnson & Johnson)
  • Excellent speaker line up. Showcasing the science and results from across the industry.
    Anne Renton (Merck)
  • Well organized and great discussions. Networking opportunities were excellent.
    Carolyn Dulney (Roche)
Back to Top
MEET THE LEADERS:

COVID-19 SAFETY

IQ Hub is committed to running this event responsibly. We believe in the power of live events and are determined to provide the most content-rich agenda and enhanced networking opportunities for our attendees.

Throughout the COVID-19 pandemic we have monitored guidance from health officials and governments for best practices. We have consulted with other event industry professionals to enhance the safety of our registration, exhibition, and conference areas.

From check-in to session rooms, exhibit halls, meals and networking, we have taken specific steps to help you feel secure and to ensure your own safety. All new procedures are designed to help prevent transmission and to maintain physical distancing during the event.

  • All attendees will be requested to wear face masks

  • Temperature checks using non-contact thermometers

  • Hand sanitizer stations placed throughout the event area

  • Gloves provided for anyone who would like to wear them

  • Seating plan with fewer attendees per table to ensure distance

  • Tables spaced out further in conference and session rooms

  • Increased cleaning and disinfecting of high-touch areas

  • Floor markings throughout the event to direct traffic

Beyond these measures, there may be additional, venue-specific safety procedures. Please visit each venue’s web site for complete information before you travel to the event as they are subject to change with little notice. If you have any further suggestions, please send them via email to delegates@iQ-Hub.com.

Stay tuned to this website, or contact us to join the email list for the latest information.